Company Overview - Atyr Pharma (ATYR) is part of the Medical sector, which includes 1012 individual stocks and currently holds a Zacks Sector Rank of 4, indicating its relative strength within the sector [2] - Atyr Pharma belongs to the Medical - Biomedical and Genetics industry, which consists of 510 individual stocks and is currently ranked 73 in the Zacks Industry Rank [6] Performance Metrics - Atyr Pharma has returned 6.9% year-to-date, outperforming the Medical sector's average return of 4.8% [4] - The Zacks Consensus Estimate for Atyr Pharma's full-year earnings has increased by 19.4% over the past quarter, reflecting stronger analyst sentiment and an improving earnings outlook [4] - The Medical - Biomedical and Genetics industry has gained an average of 6.3% year-to-date, indicating that Atyr Pharma is performing better than its industry peers [6] Comparative Analysis - Delcath Systems, Inc. (DCTH), another Medical stock, has outperformed the sector with a year-to-date return of 11.6% and a significant increase of 132.9% in its consensus EPS estimate over the past three months [5] - Delcath Systems operates in the Medical - Instruments industry, which has seen a decline of 3.5% year-to-date and is currently ranked 129 [7]
Is aTyr Pharma (ATYR) Stock Outpacing Its Medical Peers This Year?